DT&CRO CO., Ltd. (KOSDAQ:383930)

South Korea · Delayed Price · Currency is KRW

3,360.00

+105.00 (3.23%)

At close: Apr 2, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Safety	14.34B
Safety Growth	3.53%
Clinical	11.66B
Clinical Growth	222.37%
Analysis	7.00B
Analysis Growth	8.27%
Efficacy	2.97B
Efficacy Growth	12.01%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
South Korea	35.87B
South Korea Growth	35.50%
Overseas	98.68M
Overseas Growth	-12.22%